Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: BAYER

Market Cap 37.17B 42.62B 34.42B 32.26B 60.41B 4,020B 60.82B 408B 158B 1,981B 160B 156B 6,880B P/E 2026 *
16.1x
P/E 2027 * 12.1x
Enterprise Value 68.87B 78.96B 63.76B 59.77B 112B 7,447B 113B 757B 293B 3,669B 296B 290B 12,745B EV / Sales 2026 *
1.51x
EV / Sales 2027 * 1.41x
Free-Float
100%
Yield 2026 *
0.58%
Yield 2027 * 1.96%
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 66 01/04/2022
Director/Board Member 60 01/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.21%-3.04%+44.03%+143.07% 980B
-2.48%-5.18%+52.47%+39.15% 550B
-2.14%-4.94%+16.83%+57.08% 382B
+0.25%-3.09%+23.33%+16.04% 316B
+0.61%-1.69%+27.35%+13.73% 272B
+0.22%-3.10%+24.67%+30.49% 268B
+4.59%+1.98%-38.43%-46.26% 199B
-1.19%-4.95%+16.68%+47.69% 182B
-1.35%-1.46%+14.06%+59.26% 154B
Average -0.30%-3.02%+20.11%+40.03% 366.93B
Weighted average by Cap. -0.78%-3.68%+29.49%+63.31%

Financials

2026 *2027 *
Net sales 45.54B 52.21B 42.16B 39.52B 74B 4,924B 74.51B 500B 194B 2,426B 196B 192B 8,428B 46.81B 53.66B 43.34B 40.62B 76.06B 5,062B 76.58B 514B 199B 2,494B 201B 197B 8,662B
Net income 2.17B 2.49B 2.01B 1.88B 3.53B 235B 3.55B 23.86B 9.24B 116B 9.34B 9.14B 402B 3B 3.43B 2.77B 2.6B 4.87B 324B 4.9B 32.92B 12.75B 160B 12.89B 12.61B 554B
Net Debt 31.7B 36.34B 29.35B 27.51B 51.51B 3,428B 51.86B 348B 135B 1,689B 136B 133B 5,866B 28.63B 32.82B 26.5B 24.84B 46.52B 3,095B 46.83B 315B 122B 1,525B 123B 120B 5,297B
Logo BAYER
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!